Taysha Gene Therapies shares owned by UBS Group
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.0k | 3.9k | 1.77 |
| 2023-09-30 | $1.7k | 550 | 3.16 |
| 2023-06-30 | $5.2k | 7.9k | 0.66 |
| 2023-03-31 | $2.8k | 3.6k | 0.80 |
| 2022-12-31 | $456k | 202k | 2.26 |
| 2022-09-30 | $0 | 6.3k | 0.00 |
| 2022-06-30 | $352k | 95k | 3.72 |
| 2022-03-31 | $368k | 68k | 5.41 |
| 2021-12-31 | $594k | 51k | 11.64 |
| 2021-09-30 | $622k | 33k | 18.63 |
| 2021-06-30 | $112k | 5.3k | 21.13 |
| 2021-03-31 | $735k | 36k | 20.30 |
| 2020-12-31 | $953k | 36k | 26.67 |
| 2020-09-30 | $257k | 11k | 23.33 |